Mark Carpenter Selected Research

Mark Carpenter Research Topics

Disease

12	Neoplasms (Cancer) 01/2009 - 08/2002
3	Breast Neoplasms (Breast Cancer) 06/2009 - 09/2003
2	Carcinoma (Carcinomatosis) 01/2009 - 08/2002
2	Carcinogenesis 05/2006 - 09/2005
2	Pancreatic Neoplasms (Pancreatic Cancer) 12/2005 - 11/2002
1	Pleural Empyema (Pyothorax) 03/2010
1	Prostatic Neoplasms (Prostate Cancer) 01/2009
1	Fetal Alcohol Spectrum Disorders 06/2007
1	Body Weight (Weight, Body) 05/2006
1	Diarrhea 12/2005
1	Flushing 09/2005
1	Blister (Bulla) 09/2005
1	Colorectal Neoplasms (Colorectal Cancer) 01/2004
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2003
1	Nausea 12/2002
1	Acidosis 12/2002
1	Vomiting 12/2002
1	Hypoxia (Hypoxemia) 08/2002
1	Infections 08/2002
1	Lung Neoplasms (Lung Cancer) 08/2002

Drug/Important Bio-Agent (IBA)

4	Monoclonal AntibodiesIBA 10/2005 - 03/2003
3	Cetuximab (Erbitux)FDA Link 11/2004 - 11/2002
2	PolyphenolsIBA 06/2009 - 05/2006
2	Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA 12/2005 - 04/2004
2	Pharmaceutical PreparationsIBA 11/2004 - 03/2003
2	Paclitaxel (Taxol)FDA LinkGeneric 09/2003 - 03/2003
2	ErbB Receptors (EGF Receptor)IBA 03/2003 - 11/2002
1	Heparin (Liquaemin)FDA LinkGeneric 03/2010
1	bisphenol AIBA 06/2009
1	Endocrine DisruptorsIBA 06/2009
1	Methylnitrosourea (N-Methyl-N-nitrosourea)IBA 01/2009
1	GenisteinIBA 01/2009
1	Phytoestrogens (Phytoestrogen)IBA 01/2009
1	aniracetamIBA 06/2007
1	Drinking WaterIBA 05/2006
1	ResveratrolIBA 05/2006
1	anthraceneIBA 05/2006
1	Capecitabine (Xeloda)FDA Link 12/2005
1	Messenger RNA (mRNA)IBA 12/2005
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2005
1	Thymidine PhosphorylaseIBA 12/2005
1	Single-Chain AntibodiesIBA 11/2005
1	StreptavidinIBA 11/2005
1	Glycoproteins (Glycoprotein)IBA 11/2005
1	Proteins (Proteins, Gene)FDA Link 11/2005
1	AntibodiesIBA 10/2005
1	tumor-associated antigen 72IBA 10/2005
1	TECAIBA 09/2005
1	Biological ProductsIBA 09/2005
1	hydroxide ionIBA 11/2004
1	Fluorouracil (Carac)FDA LinkGeneric 04/2004
1	EmulsionsIBA 01/2004
1	Epithelial Cell Adhesion MoleculeIBA 01/2004
1	VaccinesIBA 01/2004
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2004
1	monophosphoryl lipid AIBA 01/2004
1	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2003
1	tigatuzumabIBA 09/2003
1	AntigensIBA 03/2003
1	Peptides (Polypeptides)IBA 03/2003
1	Bombesin Receptors (Bombesin Receptor)IBA 03/2003
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 03/2003
1	Taxoids (Taxanes)IBA 03/2003
1	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 12/2002
1	Ephedrine FDA LinkGeneric 12/2002
1	Tyrosine (L-Tyrosine)FDA Link 11/2002
1	Epidermal Growth Factor (EGF)IBA 11/2002
1	Gemcitabine FDA Link 11/2002
1	CaspasesIBA 08/2002
1	enhanced green fluorescent proteinIBA 08/2002
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2002
1	bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA 08/2002

Therapy/Procedure

2	Therapeutics 05/2006 - 12/2002
2	Radiotherapy 12/2005 - 09/2003
2	Drug Therapy (Chemotherapy) 04/2004 - 09/2003
1	Chemoprevention 01/2009
1	Osteotomy 09/2005
1	Operative Surgical Procedures 04/2004
1	Injections 01/2004
1	Spinal Anesthesia 12/2002